arrow
B

Betül Baykan

emar medical center
H指数:45
被引数:7,569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SLC7A6OS Founder Mutation: A Rare Cause of Progressive Myoclonus Epilepsy Dated to 1100 Years Ago

<i>SLC7A6OS</i>始祖突变:一种可追溯至1100年前的进行性肌阵挛癫痫的罕见病因

2026-09-180
OAAI
International evaluation of the SEIZUre Risk in Encephalitis (SEIZURE) score for predicting acute seizure risk

国际评估用于预测急性癫痫发作风险的脑炎癫痫发作(SEIZURE)评分中的发作风险

2025-12-051
OA
Presence of interictal epileptiform EEG discharges implies increased risk of recurrence after the first unprovoked seizure: Report of the International League Against Epilepsy and International Federation of Clinical Neurophysiology

间癫痫性痫样EEG放电的存在意味着首次非诱发性癫痫发作后复发的风险增加:国际抗癫痫联盟和国际临床神经生理学联合会的报告

2025-09-010
OAAI
Presence of interictal epileptiform EEG discharges implies increased risk of recurrence after the first unprovoked seizure: Report of the International League Against Epilepsy and International Federation of Clinical Neurophysiology

间ictal痫样EEG放电的存在意味着首次非诱发性癫痫发作后复发的风险增加:国际抗癫痫联盟和国际临床神经生理学联合会的报告

2025-08-280
OAAI
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis
2024-08-102
PRE
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
2024-05-145
PRE
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?
2024-01-312
PRE
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis

Post-COVID-19神经系统表现的患病率和轨迹: 系统回顾和荟萃分析

2024-01-259
PRE
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

新型冠状病毒肺炎神经系统急性后遗症的评估和治疗方法: 全球新型冠状病毒肺炎神经研究联盟的共识声明和范围审查

2023-11-019
PRE
COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study)
2023-09-291
OAAI